Tirzepatide Product Introduction
Definition: Tirzepatide is a novel, dual-action glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is designed to improve glycemic control and promote weight loss in individuals with type 2 diabetes.
Function: Tirzepatide works by stimulating both GIP and GLP-1 receptors, enhancing insulin secretion, suppressing glucagon release, and improving insulin sensitivity. It helps regulate blood sugar levels and reduces appetite, leading to significant weight reduction.

Applications: Tirzepatide is used in the management of type 2 diabetes to improve glycemic control and facilitate weight loss. It is administered as a once-weekly injection and is gaining recognition for its effectiveness in managing metabolic conditions.